Member Exclusive

Cell therapy weekly: ReNeuron forms new partnership to crack Chinese market

This week: Rodeo Therapeutics secures US$5.9 million to develop small molecule regenerative therapies and AgomAb Therapeutics secures €21 million for regenerative antibodies.

Go to the profile of RegMedNet
Apr 11, 2019

Please sign in or register for FREE

No comments yet.